"Artificial intelligence (AI) drug development will be useful, but there is a problem with only talking too much hope. Domestic AI drug development is still at an early stage, so more R&D is needed." These are the words the representative of an AI drug development company attending a recently held event related to digital healthcare threw to the debaters in the audience. It seems to point out that although new drug development using AI is being carried out in various parts of the world, companies that have achieved tangible results in Korea have yet to be seen. According to the Ministry of Science and ICT, new drug development is one of the projects that take an average of 10 years or more for a new drug to come to t